Qritive
Singapore
- Singapore, Singapore
- 11/01/2023
- Unknown
- $7,500,000
Qritive makes cancer diagnosis fast, cheap, and accurate.
During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs.
- Industry Software Development
- Website https://qritive.com/
- LinkedIn https://www.linkedin.com/company/qritive/
Related People
Aneesh Sathe, Ph.D.Co Founder
United States -
ND
At Qritive, we make cancer diagnosis fast, accurate, and affordable.
Qritive provides an AI-powered solution to help doctors analyse microscopy images for histopathology. As a result, hospitals and labs will be more efficient in making cancer diagnoses, allowing them to save costs.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)